{"symbol":"ARKK","date_from":"2025-03-18","date_to":"2025-03-18","trades":[{"fund":"ARKK","date":"2025-03-18","ticker":"ILMN","company":"Illumina Inc","direction":"Sell","cusip":"US4523271090","shares":86375,"etf_percent":0.134},{"fund":"ARKK","date":"2025-03-18","ticker":"TEM","company":"Tempus AI Inc","direction":"Buy","cusip":"US88023B1035","shares":142530,"etf_percent":0.1194},{"fund":"ARKK","date":"2025-03-18","ticker":"PATH","company":"UiPath Inc","direction":"Sell","cusip":"US90364P1057","shares":482454,"etf_percent":0.096},{"fund":"ARKK","date":"2025-03-18","ticker":"GTLB","company":"GitLab Inc","direction":"Buy","cusip":"US37637K1088","shares":104699,"etf_percent":0.0957},{"fund":"ARKK","date":"2025-03-18","ticker":"AMD","company":"Advanced Micro Devices Inc","direction":"Buy","cusip":"US0079031078","shares":30324,"etf_percent":0.0571},{"fund":"ARKK","date":"2025-03-18","ticker":"IRDM","company":"Iridium Communications Inc","direction":"Buy","cusip":"US46269C1027","shares":99784,"etf_percent":0.0497},{"fund":"ARKK","date":"2025-03-18","ticker":"CRSP","company":"CRISPR Therapeutics AG","direction":"Buy","cusip":"CH0334081137","shares":56445,"etf_percent":0.0423},{"fund":"ARKK","date":"2025-03-18","ticker":"TXG","company":"10X Genomics Inc","direction":"Buy","cusip":"US88025U1097","shares":220788,"etf_percent":0.0421},{"fund":"ARKK","date":"2025-03-18","ticker":"META","company":"Meta Platforms Inc","direction":"Sell","cusip":"US30303M1027","shares":2160,"etf_percent":0.0235},{"fund":"ARKK","date":"2025-03-18","ticker":"NTLA","company":"Intellia Therapeutics Inc","direction":"Buy","cusip":"US45826J1051","shares":135862,"etf_percent":0.0226},{"fund":"ARKK","date":"2025-03-18","ticker":"PACB","company":"Pacific Biosciences of California Inc","direction":"Buy","cusip":"US69404D1081","shares":793508,"etf_percent":0.0175},{"fund":"ARKK","date":"2025-03-18","ticker":"PRME","company":"Prime Medicine Inc","direction":"Sell","cusip":"US74168J1016","shares":418160,"etf_percent":0.0133},{"fund":"ARKK","date":"2025-03-18","ticker":"RXRX","company":"Recursion Pharmaceuticals Inc","direction":"Buy","cusip":"US75629V1044","shares":81715,"etf_percent":0.0094}]}